Safety & Performance Study of Verruca Treatment Device

Status Completed

Clinical Trial Summary

This is a non comparative pre-CE marking pilot clinical investigation is required to evaluate the safety and performance in intended use of the Verruca treatment - NPD396, Class IIa medical device for verrucas in the adult population. The treatment regime will be topical application of the Verruca treatment to the verruca, identified as the reference, once daily for 4 weeks.

Patient & investigator derived outcomes will also be collected to assess clinical performance and adverse events and adverse device effects will be reported to assess safety profile.

Patient assessments will take place pre-treatment to determine patient demography, baseline clinical status, pain and verruca size prior to treatment. Compliance with treatment schedule will be collected via patient diary cards. Furthermore, patients will be assessed on day 2 after starting treatment and then again at 7, 14, 21 & 28 days after starting treatment. Diary cards will completed through-out the investigation.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01536834
Study type	Interventional
Source	Reckitt Benckiser LLC
Contact
Status	Completed
Phase	N/A
Start date	June 2012
Completion date	February 2013

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05324904` - Intralesional Vitamin D3 Versus Intralesional Acyclovir in Treatment of Plantar Warts	N/A
Completed	`NCT00328991` - Clinical Trial Evaluating Efficacy of Duct Tape for Treatment of Warts	N/A
Completed	`NCT05592041` - Studying of Natural Constituents' Treatment of Plantar Warts	Early Phase 1
Completed	`NCT05115669` - Safety & Effectiveness of Wortie Freeze Plus in Common and Plantar Warts	N/A
Recruiting	`NCT06261684` - Intralesional Acyclovir Versus Cryotherapy in the Treatment of Plantar Warts. A Randomized Controlled Trial.	Phase 2/Phase 3
Not yet recruiting	`NCT05057663` - Intralesional Treatment of Plantar Wart	N/A
Recruiting	`NCT02151630` - Pyruvic Acid Versus Salicylic Acid Preparation in Treatment of Plantar Warts	Phase 2/Phase 3
Withdrawn	`NCT04823845` - Plantar Wart Treatment Using Adapalene Gel	Early Phase 1
Completed	`NCT05588999` - Comparative Study Between Treatment With Cryotherapy Alone Versus Cryotherapy Plus Salicylic Acid Dressing for Planter Warts	Phase 1
Recruiting	`NCT05488860` - Piezoelectric Drived Microneedling in Treating Refractory Skin Diseases	N/A
Recruiting	`NCT05520658` - Evaluation of the Efficacy of Intralesional Injection of Combined Digoxin and Furosemide Versus 5 - Fluorouracil in Treatment of Plantar Warts	N/A
Not yet recruiting	`NCT04654091` - Cryotherapy VS. Nitric-zinc Complex in the Treatment of Plantar Warts.	N/A
Not yet recruiting	`NCT05599971` - Intralesional Injection of Combined Digoxin and Furosemide Versus 5-Flurouracil in Plantar Warts	N/A
Not yet recruiting	`NCT05198180` - Treatment of Plantar Warts	Phase 3
Recruiting	`NCT06214559` - Evaluate the Effectiveness and the Safety of a Medical Device in the Treatment of Common Warts and Plantar Warts.	N/A
Recruiting	`NCT03977753` - Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatment of Warts	Phase 4
Completed	`NCT03183765` - Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts	Phase 4